QUOTE AND NEWS
TheStreet.com  Aug 19  Comment 
NEW YORK (TheStreet) --aAchillion PharmaceuticalsaACHN rose in after-hours trading Tuesday after the company received a patent for its hepatitis C drug ACH-3102. The U.S.aPatent & Trademark Office granted U.S. Patent No. 8,809,313 to the company....
Benzinga  Aug 19  Comment 
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No. 8,809,313, covering composition-of-matter and method of use claims for ACH-3102 and structurally...
StreetInsider.com  Aug 18  Comment 
UPGRADES Deutsche Bank upgrades Achillion Pharmaceuticals (Nasdaq: ACHN) from Hold to Buy and moves its price target from $6 to $17. Click Here for more color. Monness, Crespi, Hardt moves Hewlett-Packard (NYSE: HPQ) from Neutral to...
TheStreet.com  Aug 18  Comment 
NEW YORK (TheStreet) --aAchillion Pharmaceuticalsa hit a 52-week high of $10.10 on Monday afteraDeutscheaupgraded the stock and increased its price target 183%. Deutsche upgraded the stock to "buy" from "hold" and increased the price target to...
Benzinga  Aug 18  Comment 
Shares of Achillion Pharmaceuticals (NASDAQ: ACHN) are trading higher after Deutsche Bank upgraded the stock from Hold to Buy and raised the price target from $6 to $17. In the past, key concerns surrounded clinical and management execution....
Benzinga  Aug 18  Comment 
Sky-mobi (NASDAQ: MOBI) jumped 16.24% to $7.80 in pre-market trading after the company announced unaudited Q2 financial results. Dollar General (NYSE: DG) shares jumped 8.77% to $62.50 in pre-market trading after the company offered to buy...
StreetInsider.com  Aug 15  Comment 
52-Week High: Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) $10.20. Achillion Pharma ripping today after it announced interim results from an ongoing Phase 2 proxy study evaluating ACH-3102, Achillion's second-generation NS5A inhibitor, in...
Motley Fool  Aug 15  Comment 
Achillion stock is among the top gainers as its experimental hepatitis C combination therapy delivers "perfect" results.
StreetInsider.com  Aug 15  Comment 
The following is a list of notable articles to help get you through the lunch hour: Ukraine Forces Attacked, Destroyed Part of Armed Convoy from Russia - Ukraine's Lysenko (RSX) (SPY) (QQQ) -> Read this! Canaccord Comments on NPS Pharma (NPSP)...
Benzinga  Aug 15  Comment 
Monster Beverage (NASDAQ: MNST) jumped 20.74% to $86.51 in pre-market trading. Coca-Cola Company (NYSE: KO) and Monster Beverage announced a long-term strategic partnership. As part of the deal, Coca-Cola will buy a 16.7% equity stake in...





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki